Coronavirus Update: Veklury Shows Mortality Benefit In Real-World Data Analyses
Vir/GSK Announce Positive Phase III Data For Sotrovimab
Sotrovimab data could help with uptake, though the market remains challenging as infections fall. Plus RedHill presents encouraging Phase II data for oral drug to treat COVID-19 infection and inflammation after completing Phase II/III study enrollment and Japan taps its world-leading supercomputer.
